Patient-reported factors associated with discontinuing employment following head and neck cancer treatment.
OBJECTIVE
To evaluate patients' reported reasons for discontinuing employment following treatment for head and neck cancer (HNC). Discontinuing employment is a serious problem for patients with HNC and has an impact on many aspects of their lives.


METHODS
Prospective, observational outcomes study.


METHODS
Tertiary care institution.


METHODS
A total of 666 patients with carcinomas of the head and neck who were treated from January 1, 1998, to October 31, 2004.


METHODS
Patients provided information about the status of their employment at the time of diagnosis and then at 3, 6, 9, and 12 months after diagnosis. Patients who discontinued employment after treatment rated the importance of 5 factors (eating, speech, appearance, pain or discomfort, and fatigue) in that decision.


METHODS
The 5 factors were scored on a 5-point Likert scale (5 being most important) as to their importance in the decision to discontinue work. The relationships of patient, disease, and treatment variables to employment status were evaluated.


RESULTS
Of the 666 patients, 239 were employed at the time of their diagnosis. After treatment, 91 (38.1%) of the 239 reported discontinuing work because of their cancer and treatment. Eighty-two (90.1%) of these 91 patients rated each of the 5 factors. Fatigue had the highest percentage (58.5%) of 4 or 5 ratings, followed by speech (51.2%), eating (45.1%), pain or discomfort (37.8%), and appearance (17.1%). Thirty-seven (40.7%) of the 91 patients who discontinued work returned to work within 1 year of treatment.


CONCLUSIONS
Identification of the factors associated with the decision to discontinue work is a first step in providing focused solutions to minimize disability.
Buckwalter
Andrea E
AE
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, The University of Iowa, Iowa City, IA 52242-1093, USA.
Karnell
Lucy Hynds
LH
Smith
Russell B
RB
Christensen
Alan J
AJ
Funk
Gerry F
GF
D000368:Aged; D002277:Carcinoma / Q000453:epidemiology* / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000453:epidemiology* / Q000628:therapy*; D006801:Humans; D008297:Male; D015995:Prevalence; D011446:Prospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D014478:Unemployment / Q000706:statistics & numerical data*